Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

A castrated dog developed hair loss and prostate issues from long-term exposure to estrogen cream.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

CEC levels may be a useful marker for predicting prostate cancer progression.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Certain genetic markers can indicate a person's risk of developing prostate cancer.

Finasteride treatment makes the prostate look more like a healthy one.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

There is no link between hair loss and prostate enlargement.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Hair loss can be an early sign of prostate enlargement.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Gene variation affects prostate issues and hair loss.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Large prostate patients more likely to have hair loss.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Early baldness in men may indicate a higher risk of prostate cancer.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.